Sanofi Adr Stock Probability Of Bankruptcy

SNY Stock

USD 47.98 0.20 0.42%

Sanofi ADR's odds of distress is below 1% at this time. The company is very unlikely to encounter any financial distress in the next two years. Probability of bankruptcy shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Sanofi balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Sanofi ADR Piotroski F Score and Sanofi ADR Altman Z Score analysis.

For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

Market Cap is likely to rise to about 60.9 B in 2024, whereas Enterprise Value is likely to drop slightly above 65.8 B in 2024.

Sanofi ADR Company probability of bankruptcy Analysis

Sanofi ADR's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Sanofi ADR Probability Of Bankruptcy

Less than 1%

Most of Sanofi ADR's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sanofi ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Sanofi ADR probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Sanofi ADR odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Sanofi ADR financial health.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.115

Earnings Share

1.9

Revenue Per Share

19.3565

Return On Assets

0.0416

Return On Equity

0.0582

The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Sanofi Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Sanofi ADR is extremely important. It helps to project a fair market value of Sanofi Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Sanofi ADR's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sanofi ADR's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sanofi ADR's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Retained Earnings	Long Term Debt	Property Plant Equipment	Treasury Stock	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.66	0.84	0.85	1.0	-0.61	0.98	0.9	0.6	0.79	0.84	0.15	0.02	0.68	0.56	0.01	0.48	0.32	-0.52	-0.02	0.57	0.55	0.43	-0.19	-0.02
Total Stockholder Equity	0.99		0.56	0.84	0.84	0.99	-0.6	0.95	0.9	0.58	0.78	0.84	0.1	0.02	0.63	0.59	-0.02	0.5	0.33	-0.5	0.08	0.52	0.5	0.43	-0.18	-0.01
Net Debt	0.66	0.56		0.56	0.6	0.66	-0.32	0.77	0.47	0.52	0.7	0.48	0.25	-0.11	0.64	0.25	0.25	0.35	0.16	-0.33	-0.65	0.61	0.54	0.38	-0.41	-0.05
Accounts Payable	0.84	0.84	0.56		0.57	0.84	-0.26	0.8	0.77	0.4	0.59	0.46	-0.18	-0.08	0.41	0.28	-0.05	0.69	0.31	-0.65	-0.02	0.75	0.69	0.66	-0.48	0.04
Net Receivables	0.85	0.84	0.6	0.57		0.85	-0.82	0.85	0.7	0.63	0.74	0.89	0.52	0.05	0.68	0.65	-0.03	0.03	0.22	-0.25	-0.08	0.21	0.21	0.09	-0.12	-0.12
Good Will	1.0	0.99	0.66	0.84	0.85		-0.6	0.98	0.9	0.58	0.79	0.83	0.16	0.01	0.7	0.57	-0.03	0.48	0.34	-0.55	-0.04	0.56	0.53	0.42	-0.2	-0.03
Short Term Investments	-0.61	-0.6	-0.32	-0.26	-0.82	-0.6		-0.59	-0.46	-0.29	-0.46	-0.87	-0.72	-0.19	-0.57	-0.65	0.16	0.29	0.18	0.2	0.02	0.09	0.03	0.19	0.15	-0.02
Total Liab	0.98	0.95	0.77	0.8	0.85	0.98	-0.59		0.89	0.6	0.79	0.81	0.21	0.01	0.72	0.51	0.04	0.44	0.31	-0.54	-0.16	0.62	0.59	0.41	-0.2	-0.04
Total Current Assets	0.9	0.9	0.47	0.77	0.7	0.9	-0.46	0.89		0.51	0.52	0.7	0.06	0.17	0.54	0.36	-0.01	0.43	0.44	-0.64	0.16	0.66	0.68	0.39	0.02	-0.04
Short Term Debt	0.6	0.58	0.52	0.4	0.63	0.58	-0.29	0.6	0.51		0.63	0.55	0.07	0.13	0.25	0.27	0.35	0.23	0.25	0.1	-0.09	0.35	0.34	0.35	-0.09	0.07
Intangible Assets	0.79	0.78	0.7	0.59	0.74	0.79	-0.46	0.79	0.52	0.63		0.73	0.04	-0.21	0.56	0.53	0.16	0.49	0.2	-0.13	-0.22	0.35	0.27	0.47	-0.24	0.15
Common Stock	0.84	0.84	0.48	0.46	0.89	0.83	-0.87	0.81	0.7	0.55	0.73		0.43	0.1	0.69	0.74	-0.01	0.08	0.08	-0.29	0.03	0.16	0.18	0.12	-0.06	0.13
Current Deferred Revenue	0.15	0.1	0.25	-0.18	0.52	0.16	-0.72	0.21	0.06	0.07	0.04	0.43		0.26	0.39	0.32	-0.23	-0.71	-0.13	0.1	-0.23	-0.37	-0.3	-0.69	0.05	-0.42
Retained Earnings	0.02	0.02	-0.11	-0.08	0.05	0.01	-0.19	0.01	0.17	0.13	-0.21	0.1	0.26		-0.13	-0.11	0.07	-0.18	0.14	-0.08	0.41	0.04	0.22	-0.24	0.12	-0.11
Long Term Debt	0.68	0.63	0.64	0.41	0.68	0.7	-0.57	0.72	0.54	0.25	0.56	0.69	0.39	-0.13		0.77	0.07	0.16	0.36	-0.5	-0.34	0.24	0.2	0.09	-0.02	-0.13
Property Plant Equipment	0.56	0.59	0.25	0.28	0.65	0.57	-0.65	0.51	0.36	0.27	0.53	0.74	0.32	-0.11	0.77		0.13	0.06	0.16	-0.14	0.1	-0.13	-0.16	-0.04	-0.01	-0.06
Treasury Stock	0.01	-0.02	0.25	-0.05	-0.03	-0.03	0.16	0.04	-0.01	0.35	0.16	-0.01	-0.23	0.07	0.07	0.13		0.26	0.0	0.24	0.0	0.31	0.32	0.24	-0.12	0.11
Deferred Long Term Liab	0.48	0.5	0.35	0.69	0.03	0.48	0.29	0.44	0.43	0.23	0.49	0.08	-0.71	-0.18	0.16	0.06	0.26		0.34	-0.42	0.02	0.73	0.63	0.84	-0.3	0.23
Long Term Investments	0.32	0.33	0.16	0.31	0.22	0.34	0.18	0.31	0.44	0.25	0.2	0.08	-0.13	0.14	0.36	0.16	0.0	0.34		-0.31	0.16	0.25	0.24	0.12	0.4	-0.37
Short Long Term Debt	-0.52	-0.5	-0.33	-0.65	-0.25	-0.55	0.2	-0.54	-0.64	0.1	-0.13	-0.29	0.1	-0.08	-0.5	-0.14	0.24	-0.42	-0.31		0.11	-0.64	-0.66	-0.47	0.25	-0.22
Net Tangible Assets	-0.02	0.08	-0.65	-0.02	-0.08	-0.04	0.02	-0.16	0.16	-0.09	-0.22	0.03	-0.23	0.41	-0.34	0.1	0.0	0.02	0.16	0.11		-0.21	-0.1	-0.16	0.4	-0.09
Long Term Debt Total	0.57	0.52	0.61	0.75	0.21	0.56	0.09	0.62	0.66	0.35	0.35	0.16	-0.37	0.04	0.24	-0.13	0.31	0.73	0.25	-0.64	-0.21		0.98	0.76	-0.39	0.18
Capital Surpluse	0.55	0.5	0.54	0.69	0.21	0.53	0.03	0.59	0.68	0.34	0.27	0.18	-0.3	0.22	0.2	-0.16	0.32	0.63	0.24	-0.66	-0.1	0.98		0.68	-0.35	0.2
Net Invested Capital	0.43	0.43	0.38	0.66	0.09	0.42	0.19	0.41	0.39	0.35	0.47	0.12	-0.69	-0.24	0.09	-0.04	0.24	0.84	0.12	-0.47	-0.16	0.76	0.68		-0.5	0.61
Net Working Capital	-0.19	-0.18	-0.41	-0.48	-0.12	-0.2	0.15	-0.2	0.02	-0.09	-0.24	-0.06	0.05	0.12	-0.02	-0.01	-0.12	-0.3	0.4	0.25	0.4	-0.39	-0.35	-0.5		-0.38
Capital Stock	-0.02	-0.01	-0.05	0.04	-0.12	-0.03	-0.02	-0.04	-0.04	0.07	0.15	0.13	-0.42	-0.11	-0.13	-0.06	0.11	0.23	-0.37	-0.22	-0.09	0.18	0.2	0.61	-0.38

Click cells to compare fundamentals

The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Competition

Predict Sanofi ADR

Based on the latest financial disclosure, Sanofi ADR has a Probability Of Bankruptcy of 1.0%. This is 97.69% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 97.49% higher than that of the company.

Sanofi Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sanofi ADR's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sanofi ADR could also be used in its relative valuation, which is a method of valuing Sanofi ADR by comparing valuation metrics of similar companies.

Sanofi ADR is currently under evaluation in probability of bankruptcy category among its peers.

Sanofi ADR Main Bankruptcy Drivers

	2019	2020	2021	2022	2023	2024 (projected)
Return On Assets	0.0245	0.11	0.0518	0.0661	0.0427	0.0802
Net Debt	16.5B	9.8B	12.3B	8.5B	9.7B	7.6B
Total Current Liabilities	20.4B	19.3B	21.3B	24.0B	24.2B	14.4B
Non Current Liabilities Total	33.0B	31.9B	29.9B	27.6B	27.9B	23.6B
Total Assets	112.6B	114.4B	120.2B	126.7B	126.5B	88.7B
Total Current Assets	28.9B	33.8B	30.7B	34.1B	30.7B	22.2B
Total Cash From Operating Activities	7.7B	7.4B	10.5B	10.5B	10.3B	7.4B

Sanofi ADR ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sanofi ADR's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sanofi ADR's managers, analysts, and investors.

Environmental

Governance

Social

Sanofi Fundamentals

	Return On Equity	0.0582
	Return On Asset	0.0416
	Profit Margin	0.09 %
	Operating Margin	0.29 %
	Current Valuation	138.72 B
	Shares Outstanding	2.51 B
	Shares Owned By Institutions	11.64 %
	Number Of Shares Shorted	8.12 M
	Price To Earning	7.78 X
	Price To Book	1.55 X
	Price To Sales	2.50 X
	Revenue	46.03 B
	Gross Profit	31.7 B
	EBITDA	12.6 B
	Net Income	5.4 B
	Cash And Equivalents	6.9 B
	Cash Per Share	2.76 X
	Total Debt	18.42 B
	Debt To Equity	0.30 %
	Current Ratio	1.30 X
	Book Value Per Share	58.10 X
	Cash Flow From Operations	10.26 B
	Short Ratio	4.07 X
	Earnings Per Share	1.90 X
	Price To Earnings To Growth	0.74 X
	Target Price	63.49
	Number Of Employees	86.09 K
	Beta	0.45
	Market Capitalization	121.14 B
	Total Asset	126.46 B
	Retained Earnings	67.5 B
	Working Capital	6.46 B
	Current Asset	24.93 B
	Current Liabilities	16.82 B
	Annual Yield	0.04 %
	Five Year Return	3.85 %
	Net Asset	126.46 B

About Sanofi ADR Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sanofi ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanofi ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanofi ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for Sanofi Stock Analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sanofi Adr Stock Probability Of Bankruptcy

Sanofi ADR Company probability of bankruptcy Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Sanofi ADR Probability Of Bankruptcy

Sanofi Probability Of Bankruptcy Driver Correlations

Sanofi Probability Of Bankruptcy Peer Comparison

Sanofi ADR Main Bankruptcy Drivers

Sanofi ADR ESG Sustainability

Sanofi Fundamentals

About Sanofi ADR Fundamental Analysis

Also Currently Popular

Additional Tools for Sanofi Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY